JD Supra

Tiny Chains, Big Changes? What FDA’s Latest Actions Mean for Peptide Compounding

FDA will convene the Pharmacy Compounding Advisory Committee (PCAC) on July 23-24, 2026, to discuss seven peptides for potential inclusion on the 503A bulks list. An additional five peptides will be ...
JD Supra

Compounding At The Crossroads: FDA AdComm Recommends Adding Six Peptides To The 503A Bulk Drug Substances List

The Pharmacy Compounding Advisory Committee (AdComm) of the United States Food and Drug Administration (FDA) recently voted to add six peptides to the List of Bulk Drug Substances That Can Be Used To ...
Yahoo Finance

Vanta Commends U.S. FDA Advisory Committee Vote Recommending Inclusion of Six Peptide Substances on FDA's 503A Bulks List, Including BPC-157, TB-500 and MOTS-c

News Release Highlights: U.S. FDA Pharmacy Compounding Advisory Committee recommends the inclusion of six peptide substances, ... · ACCESS Newswire · Vanta Holdings Inc. Vanta Holdings Inc. The ...
RAPS

Drug Compounding With Bulk Substances: FDA Offers Interim Policies

The US Food and Drug Administration (FDA) late Friday issued revised versions of two final guidance documents explaining the use of bulk drug substances in compounding and clarifying that the agency ...
MedPage Today on MSN

FDA warns pharmacy about illegal GLP-1 compounding

Agency's letter flagged issues with copycat manufacturing and sterility ...

Compounding Pharmacies for Weight-Loss Drugs Are Booming. Should You Trust Them?

As more people turn to telehealth for GLP-1s, one type of pharmacy is coming under scrutiny.
newswire

Vanta Commends U.S. FDA Advisory Committee Vote Recommending Inclusion of Six Peptide Substances on FDA's 503A Bulks List, Including BPC-157, TB-500 and MOTS-c

U.S. FDA Pharmacy Compounding Advisory Committee recommends the inclusion of six peptide substances, including BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax, on the FDA's 503A Bulks List, ...